BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 36966973)

  • 1. Lipocalin family proteins and their diverse roles in cardiovascular disease.
    Yang HH; Wang X; Li S; Liu Y; Akbar R; Fan GC
    Pharmacol Ther; 2023 Apr; 244():108385. PubMed ID: 36966973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lipocalin protein family: structure and function.
    Flower DR
    Biochem J; 1996 Aug; 318 ( Pt 1)(Pt 1):1-14. PubMed ID: 8761444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The menagerie of human lipocalins: a natural protein scaffold for molecular recognition of physiological compounds.
    Schiefner A; Skerra A
    Acc Chem Res; 2015 Apr; 48(4):976-85. PubMed ID: 25756749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMR solution structure of lipocalin-type prostaglandin D synthase: evidence for partial overlapping of catalytic pocket and retinoic acid-binding pocket within the central cavity.
    Shimamoto S; Yoshida T; Inui T; Gohda K; Kobayashi Y; Fujimori K; Tsurumura T; Aritake K; Urade Y; Ohkubo T
    J Biol Chem; 2007 Oct; 282(43):31373-9. PubMed ID: 17715133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-binding properties of human ApoD and Lazarillo-related lipocalins: functional implications for cell differentiation.
    Ruiz M; Sanchez D; Correnti C; Strong RK; Ganfornina MD
    FEBS J; 2013 Aug; 280(16):3928-43. PubMed ID: 23777559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on the human and mouse lipocalin (LCN) gene family, including evidence the mouse Mup cluster is result of an "evolutionary bloom".
    Charkoftaki G; Wang Y; McAndrews M; Bruford EA; Thompson DC; Vasiliou V; Nebert DW
    Hum Genomics; 2019 Feb; 13(1):11. PubMed ID: 30782214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lipocalins retinol-binding protein-4, lipocalin-2 and lipocalin-type prostaglandin D2-synthase correlate with markers of inflammatory activity, alcohol intake and blood lipids, but not with insulin sensitivity in metabolically healthy 58-year-old Swedish men.
    Wallenius V; Elias E; Bergstrom GM; Zetterberg H; Behre CJ
    Exp Clin Endocrinol Diabetes; 2011 Feb; 119(2):75-80. PubMed ID: 21104585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serendipitous fatty acid binding reveals the structural determinants for ligand recognition in apolipoprotein M.
    Sevvana M; Ahnström J; Egerer-Sieber C; Lange HA; Dahlbäck B; Muller YA
    J Mol Biol; 2009 Nov; 393(4):920-36. PubMed ID: 19733574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compact packing of lipocalin-type prostaglandin D synthase induced by binding of lipophilic ligands.
    Inoue K; Yagi N; Urade Y; Inui T
    J Biochem; 2009 Feb; 145(2):169-75. PubMed ID: 19015161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural analysis of lipocalin-type prostaglandin D synthase complexed with biliverdin by small-angle X-ray scattering and multi-dimensional NMR.
    Miyamoto Y; Nishimura S; Inoue K; Shimamoto S; Yoshida T; Fukuhara A; Yamada M; Urade Y; Yagi N; Ohkubo T; Inui T
    J Struct Biol; 2010 Feb; 169(2):209-18. PubMed ID: 19833210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ligand recognition mechanism of lipocalin-type prostaglandin D synthase].
    Shimamoto S; Yoshida T; Ohkubo T
    Yakugaku Zasshi; 2011; 131(11):1575-81. PubMed ID: 22041695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-Based Phylogenetic Analysis of the Lipocalin Superfamily.
    Lakshmi B; Mishra M; Srinivasan N; Archunan G
    PLoS One; 2015; 10(8):e0135507. PubMed ID: 26263546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipose-Derived Lipid-Binding Proteins: The Good, the Bad and the Metabolic Diseases.
    Frances L; Tavernier G; Viguerie N
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipocalin-Type Prostaglandin D
    Islam MA; Khairnar R; Fleishman J; Thompson K; Kumar S
    Pharm Res; 2022 Nov; 39(11):2951-2963. PubMed ID: 35799081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution structures of mutants of residues that affect access to the ligand-binding cavity of human lipocalin-type prostaglandin D synthase.
    Perduca M; Bovi M; Bertinelli M; Bertini E; Destefanis L; Carrizo ME; Capaldi S; Monaco HL
    Acta Crystallogr D Biol Crystallogr; 2014 Aug; 70(Pt 8):2125-38. PubMed ID: 25084332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrophobic ligand binding properties of the human lipocalin apolipoprotein M.
    Ahnström J; Faber K; Axler O; Dahlbäck B
    J Lipid Res; 2007 Aug; 48(8):1754-62. PubMed ID: 17525477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-affinity recognition of lanthanide(III) chelate complexes by a reprogrammed human lipocalin 2.
    Kim HJ; Eichinger A; Skerra A
    J Am Chem Soc; 2009 Mar; 131(10):3565-76. PubMed ID: 19227970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human plasma lipocalins and serum albumin: Plasma alternative carriers?
    di Masi A; Trezza V; Leboffe L; Ascenzi P
    J Control Release; 2016 Apr; 228():191-205. PubMed ID: 26951925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic interaction analysis of human lipocalin-type prostaglandin D synthase with small lipophilic ligands.
    Kume S; Lee YH; Miyamoto Y; Fukada H; Goto Y; Inui T
    Biochem J; 2012 Sep; 446(2):279-89. PubMed ID: 22677050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple molecular recognition properties of the lipocalin protein family.
    Flower DR
    J Mol Recognit; 1995; 8(3):185-95. PubMed ID: 8573354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.